Has Tony Wang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,279 in general payments to Tony Wang, MD across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tony Wang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tony Wang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tony Wang, MD

Neurological Surgery · Seattle, WANPI 1356684948

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $26,279 with a category attached, or 76.1%. Abbott accounts for 76.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $20,070 and has fallen 92.4% since, to $1,521 in 2025.

$26,279in general payments, 2019–2025

Across 37 payments — averaging $710.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$20K
Insightec,inc$4K
Boston Scientific$1K
Medtronic$342
Penumbra, Inc.$176
Nevro Corp.$102

What the payments were for

Grants$20,00076%
Travel & lodging$4,03615%
Food & beverage$2,1738%
Education$700%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	1	$20,000
Insightec,inc	18	$4,304
Boston Scientific	11	$1,355
Medtronic	4	$342
Penumbra, Inc.	1	$176
Nevro Corp.	2	$102

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,279 in reported general payments places this provider in the 85th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$189,782

Medicare patients

236

Services billed

574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	15	$117

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Seattle

Rod OskouianSeattle$2.4M
Christoph HofstetterSeattle$768K
Stephen MonteithSeattle$151K
Jean-Christophe LevequeSeattle$120K
Vijay YanamadalaSeattle$85K
Hoan Vu TranSeattle$78K
Martin RutkowskiSeattle$62K
Bailey ZampellaSeattle$38K
Melanie WalkerSeattle$38K
Elias EliasSeattle$35K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →